1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Global Rheumatoid Arthritis Drugs Industry Report 2015

Global Rheumatoid Arthritis Drugs Industry Report 2015

  • August 2015
  • -
  • QY Research Group
  • -
  • 266 pages

Summary


The Global Rheumatoid Arthritis Drugs Industry Report 2015 is a professional and in-depth study on the current state of the Rheumatoid Arthritis Drugs industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Rheumatoid Arthritis Drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Rheumatoid Arthritis Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 270 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Rheumatoid Arthritis Drugs Industry Report 2015
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Rheumatoid Arthritis Drugs
1.2 Classification of Rheumatoid Arthritis Drugs
1.3 Applications of Rheumatoid Arthritis Drugs
1.4 Industry Chain Structure of Rheumatoid Arthritis Drugs
1.5 Industry Regional Overview of Rheumatoid Arthritis Drugs
1.6 Industry Policy Analysis of Rheumatoid Arthritis Drugs
1.7 Industry News Analysis of Rheumatoid Arthritis Drugs

2 Manufacturing Cost Structure Analysis of Rheumatoid Arthritis Drugs
2.1 Raw Material Suppliers and Price Analysis of Rheumatoid Arthritis Drugs
2.2 Equipment Suppliers and Price Analysis of Rheumatoid Arthritis Drugs
2.3 Labor Cost Analysis of Rheumatoid Arthritis Drugs
2.4 Other Costs Analysis of Rheumatoid Arthritis Drugs
2.5 Manufacturing Cost Structure Analysis of Rheumatoid Arthritis Drugs
2.6 Manufacturing Process Analysis of Rheumatoid Arthritis Drugs

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Rheumatoid Arthritis Drugs Manufacturers in 2014
3.3 RandD Status and Technology Source of Global Rheumatoid Arthritis Drugs Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Rheumatoid Arthritis Drugs Key Manufacturers in 2014

4 Production Analysis of Rheumatoid Arthritis Drugs by Regions, Technology, and Applications
4.1 Global Production of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015
4.2 Global Production of Rheumatoid Arthritis Drugs by Technology 2010-2015
4.3 Global Production of Rheumatoid Arthritis Drugs by Applications 2010-2015
4.4 Price Analysis of Global Rheumatoid Arthritis Drugs Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost and Revenue of Rheumatoid Arthritis Drugs 2010-2015
4.6 EU Capacity, Production, Price, Cost and Revenue of Rheumatoid Arthritis Drugs 2010-2015
4.7 Japan Capacity, Production, Price, Cost and Revenue of Rheumatoid Arthritis Drugs 2010-2015
4.8 China Capacity, Production, Price, Cost and Revenue of Rheumatoid Arthritis Drugs 2010-2015
4.9 US Supply, Import, Export and Consumption of Rheumatoid Arthritis Drugs 2010-2015
4.10 EU Supply, Import, Export and Consumption of Rheumatoid Arthritis Drugs 2010-2015
4.11 Japan Supply, Import, Export and Consumption of Rheumatoid Arthritis Drugs 2010-2015
4.12 China Supply, Import, Export and Consumption of Rheumatoid Arthritis Drugs 2010-2015

5 Sales and Revenue Analysis of Rheumatoid Arthritis Drugs by Regions
5.1 Global Sales of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015
5.2 Global Revenue of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015
5.3 Global Price Analysis of Rheumatoid Arthritis Drugs Sales by Regions (US, EU, China, Japan, etc.) 2010-2015
5.4 Global Price, Cost and Gross of Rheumatoid Arthritis Drugs 2010-2015

6 Analysis of Rheumatoid Arthritis Drugs Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Rheumatoid Arthritis Drugs 2010-2015
6.2 Production Market Share Analysis of Rheumatoid Arthritis Drugs 2010-2015
6.3 Sales Overview of Rheumatoid Arthritis Drugs 2010-2015
6.4 Supply, Sales and Shortage of Rheumatoid Arthritis Drugs 2010-2015
6.5 Import, Export and Consumption of Rheumatoid Arthritis Drugs 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Rheumatoid Arthritis Drugs 2010-2015

7 Analysis of Rheumatoid Arthritis Drugs Industry Key Manufacturers
7.1 Bristol-Myers Squibb Co.
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity Production Price Cost Production Value
7.1.4 Contact Information

7.2 Amgen Inc.
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity Production Price Cost Production Value
7.2.4 Contact Information

7.3 F. Hoffmann-La Roche Ltd.
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity Production Price Cost Production Value
7.3.4 Contact Information

7.4 Pfizer Inc.
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity Production Price Cost Production Value
7.4.4 Contact Information

7.5 AbbVie Inc.
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity Production Price Cost Production Value
7.5.4 Contact Information

7.6 Janssen Pharmaceuticals Inc.
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity Production Price Cost Production Value
7.6.4 Contact Information

7.7 Rigel Pharmaceuticals Inc.
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity Production Price Cost Production Value
7.7.4 Contact Information

7.8 Sanofi
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity Production Price Cost Production Value
7.8.4 Contact Information

7.9 Takeda Pharmaceutical Co. Ltd.
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity Production Price Cost Production Value
7.9.4 Contact Information

7.10 UCB SA
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity Production Price Cost Production Value
7.10.4 Contact Information

7.11 Vertex Pharmaceuticals Inc.
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity Production Price Cost Production Value
7.11.4 Contact Information

7.12 Incyte Corp.
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity Production Price Cost Production Value
7.12.4 Contact Information

7.13 Merck and Co. Inc.
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity Production Price Cost Production Value
7.13.4 Contact Information

7.14 Mitsubishi Tanabe Pharma Corp.
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity Production Price Cost Production Value
7.14.4 Contact Information

7.15 Novartis AG
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity Production Price Cost Production Value
7.15.4 Contact Information

7.16 Novo Nordisk A/S
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity Production Price Cost Production Value
7.16.4 Contact Information

7.17 Daiichi Sankyo Co. Ltd.
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity Production Price Cost Production Value
7.17.4 Contact Information

7.18 Eli Lilly and Co.
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity Production Price Cost Production Value
7.18.4 Contact Information

7.19 GE Healthcare Co.
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity Production Price Cost Production Value
7.19.4 Contact Information

7.20 Genmab A/S
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity Production Price Cost Production Value
7.20.4 Contact Information

7.21 GSK plc
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity Production Price Cost Production Value
7.21.4 Contact Information

7.22 AstraZeneca plc
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity Production Price Cost Production Value
7.22.4 Contact Information

7.23 Biogen Idec Inc.
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity Production Price Cost Production Value
7.23.4 Contact Information

7.24 Boehringer Ingelheim GmbH
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity Production Price Cost Production Value
7.24.4 Contact Information

7.25 Celgene Corp.
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity Production Price Cost Production Value
7.25.4 Contact Information

7.26 AB Science SA
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity Production Price Cost Production Value
7.26.4 Contact Information

7.27 Astellas Pharma Inc.
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity Production Price Cost Production Value
7.27.4 Contact Information

8 Price and Gross Margin Analysis
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Rheumatoid Arthritis Drugs Product Types
8.5 Market Share Analysis of Different Rheumatoid Arthritis Drugs Price Levels
8.6 Gross Margin Analysis of Different Rheumatoid Arthritis Drugs Applications

9 Marketing Trader or Distributor Analysis of Rheumatoid Arthritis Drugs
9.1 Marketing Channels Status of Rheumatoid Arthritis Drugs
9.2 Traders or Distributors of Rheumatoid Arthritis Drugs with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Rheumatoid Arthritis Drugs
9.4 Regional Import, Export and Trade Analysis of Rheumatoid Arthritis Drugs

10 Development Trend of Rheumatoid Arthritis Drugs Industry 2015-2020
10.1 Capacity and Production Overview of Rheumatoid Arthritis Drugs 2015-2020
10.2 Production Market Share Analysis of Rheumatoid Arthritis Drugs 2015-2020
10.3 Sales Overview of Rheumatoid Arthritis Drugs 2015-2020
10.4 Supply, Sales, and Shortage of Rheumatoid Arthritis Drugs 2015-2020
10.5 Import, Export and Consumption of Rheumatoid Arthritis Drugs 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Rheumatoid Arthritis Drugs 2015-2020

11 Industry Chain Suppliers of Rheumatoid Arthritis Drugs with Contact Information
11.1 Major Raw Materials Suppliers of Rheumatoid Arthritis Drugs with Contact Information
11.2 Manufacturing Equipment Suppliers of Rheumatoid Arthritis Drugs with Contact Information
11.3 Major Suppliers of Rheumatoid Arthritis Drugs with Contact Information
11.4 Key Consumers of Rheumatoid Arthritis Drugs with Contact Information
11.5 Supply Chain Relationship Analysis of Rheumatoid Arthritis Drugs

12 New Project Investment Feasibility Analysis of Rheumatoid Arthritis Drugs
12.1 New Project SWOT Analysis of Rheumatoid Arthritis Drugs
12.2 New Project Investment Feasibility Analysis of Rheumatoid Arthritis Drugs

13 Conclusion of the Global Rheumatoid Arthritis Drugs Industry Report 2015




List of Tables and Figures
Figure Picture of Rheumatoid Arthritis Drugs
Table Product Specifications of Rheumatoid Arthritis Drugs
Figure Global Sales Market Share of Rheumatoid Arthritis Drugs by Product Types in 2014
Figure Global Sales Market Share of Rheumatoid Arthritis Drugs by Applications in 2014
Figure Industry Chain Structure of Rheumatoid Arthritis Drugs
Table Global Major Rheumatoid Arthritis Drugs Manufacturers
Table Industry Policy of Rheumatoid Arthritis Drugs
Table Industry News List of Rheumatoid Arthritis Drugs
Table Manufacturing Cost Structure Analysis of Rheumatoid Arthritis Drugs in 2014
Figure Manufacturing Process Analysis of Rheumatoid Arthritis Drugs
Table Capacity (K MT) and Commercial Production Date of Global Rheumatoid Arthritis Drugs Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Global Key Rheumatoid Arthritis Drugs Manufacturers in 2014
Table RandD Status and Technology Source of Global Rheumatoid Arthritis Drugs Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Global and China Rheumatoid Arthritis Drugs Key Manufacturers in 2014
Table Global Production of Rheumatoid Arthritis Drugs by Regions 2010-2015 (K MT)
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Regions in 2010
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Regions in 2011
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Regions in 2012
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Regions in 2013
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Regions in 2014
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Regions in 2015
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Technology in 2010
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Technology in 2011
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Technology in 2012
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Technology in 2013
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Technology in 2014
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Technology in 2015
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Applications in 2010
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Applications in 2011
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Applications in 2012
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Applications in 2013
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Applications in 2014
Figure Global Production Market Share of Rheumatoid Arthritis Drugs by Applications in 2015
Figure Price Comparison of Global Rheumatoid Arthritis Drugs Key Manufacturers in 2015 (USD/MT)
Table US Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT) and Revenue (M USD) of Rheumatoid Arthritis Drugs 2010-2015
Table EU Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT) and Revenue (M USD) of Rheumatoid Arthritis Drugs 2010-2015
Table Japan Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT) and Revenue (M USD) of Rheumatoid Arthritis Drugs 2010-2015
Table China Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT) and Revenue (M USD) of Rheumatoid Arthritis Drugs 2010-2015
Table US Supply, Import, Export and Consumption of Rheumatoid Arthritis Drugs 2010-2015 (K MT)
Table EU Supply, Import, Export and Consumption of Rheumatoid Arthritis Drugs 2010-2015 (K MT)
Table Japan Supply, Import, Export and Consumption of Rheumatoid Arthritis Drugs 2010-2015 (K MT)
Table China Supply, Import, Export and Consumption of Rheumatoid Arthritis Drugs 2010-2015 (K MT)
Table Global Sales of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015 (K MT)
Figure Global Sales of Rheumatoid Arthritis Drugs by Regions (EU, China, Japan, etc.) in 2010 (K MT)
Figure Global Sales of Rheumatoid Arthritis Drugs by Regions (EU, China, Japan, etc.) in 2011 (K MT)
Figure Global Sales of Rheumatoid Arthritis Drugs by Regions (EU, China, Japan, etc.) in 2012 (K MT)
Figure Global Sales of Rheumatoid Arthritis Drugs by Regions (EU, China, Japan, etc.) in 2013 (K MT)
Figure Global Sales of Rheumatoid Arthritis Drugs by Regions (EU, China, Japan, etc.) in 2014 (K MT)
Figure Global Sales of Rheumatoid Arthritis Drugs by Regions (EU, China, Japan, etc.) in 2015 (K MT)
Table Global Revenue of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015 (M USD)
Figure Global Revenue of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) in 2010 (M USD)
Figure Global Revenue of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) in 2011 (M USD)
Figure Global Revenue of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) in 2012 (M USD)
Figure Global Revenue of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) in 2013 (M USD)
Figure Global Revenue of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) in 2014 (M USD)
Figure Global Revenue of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) in 2015 (M USD)
Table Sale Price of Rheumatoid Arthritis Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015 (USD/MT)
Figure Global Price Analysis of Rheumatoid Arthritis Drugs 2010-2015 (USD/MT)
Figure Global Cost Analysis of Rheumatoid Arthritis Drugs 2010-2015 (USD/MT)
Figure Global Gross Analysis of Rheumatoid Arthritis Drugs 2010-2015
Table Global and Major Manufacturers Capacity of Rheumatoid Arthritis Drugs 2010-2015 (K MT)
Table Global Capacity Market Share of Major Rheumatoid Arthritis Drugs Manufacturers 2010-2015
Table Global and Major Manufacturers Production of Rheumatoid Arthritis Drugs 2010-2015 (K MT)
Table Global Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers 2010-2015
Figure Global Capacity (K MT), Production (K MT) and Growth Rate of Rheumatoid Arthritis Drugs 2010-2015
Figure Global Capacity Utilization Rate of Rheumatoid Arthritis Drugs 2010-2015
Table Global and Major Manufacturers Revenue of Rheumatoid Arthritis Drugs 2010-2015 (M USD)
Table Global Revenue Market Share of Major Rheumatoid Arthritis Drugs Manufacturers 2010-2015
Figure Global Revenue (M USD) and Growth Rate of Rheumatoid Arthritis Drugs 2010-2015
Table China and Major Manufacturers Capacity of Rheumatoid Arthritis Drugs 2010-2015 (K MT)
Table Capacity Market Share of China Major Rheumatoid Arthritis Drugs Manufacturers 2010-2015
Table China and Major Manufacturers Production 2010-2015 (K MT)
Table Production Market Share of China Major Manufacturers 2010-2015
Figure China Capacity (K MT), Production (K MT) and Growth Rate of Rheumatoid Arthritis Drugs 2010-2015
Figure China Capacity Utilization Rate of Rheumatoid Arthritis Drugs 2010-2015
Table China and Major Manufacturers Revenue of Rheumatoid Arthritis Drugs 2010-2015 (M USD)
Table Revenue Market Share of China Major Manufacturers 2010-2015
Figure China Revenue (M USD) and Growth Rate of Rheumatoid Arthritis Drugs 2010-2015
Figure Global Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2010
Figure Global Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2011
Figure Global Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2012
Figure Global Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2013
Figure Global Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2014
Figure Global Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2015
Figure China Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2010
Figure China Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2011
Figure China Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2012
Figure China Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2013
Figure China Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2014
Figure China Production Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2015
Figure Global Sales (K MT) and Growth Rate of Rheumatoid Arthritis Drugs 2010-2015
Figure China Sales (K MT) and Growth Rate of Rheumatoid Arthritis Drugs 2010-2015
Table Global Supply, Sales and Shortage of Rheumatoid Arthritis Drugs 2010-2015 (K MT)
Table China Supply, Sales and Shortage of Rheumatoid Arthritis Drugs 2010-2015 (K MT)
Table China Import, Export and Consumption of Rheumatoid Arthritis Drugs 2010-2015 (K MT)
Table Price of Global Rheumatoid Arthritis Drugs Major Manufacturers 2010-2015 (USD/MT)
Figure Price Comparison by Global Major Rheumatoid Arthritis Drugs Manufacturers in 2014 (USD/MT)
Table Gross Margin of Global Rheumatoid Arthritis Drugs Major Manufacturers 2010-2015
Figure Gross Margin of Global Rheumatoid Arthritis Drugs Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Rheumatoid Arthritis Drugs 2010-2015 (M USD)
Table Global Revenue Market Share of Major Rheumatoid Arthritis Drugs Manufacturers 2010-2015
Figure Global Revenue Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2011
Figure Global Revenue Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2012
Figure Global Revenue Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2013
Figure Global Revenue Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2014
Figure Global Revenue Market Share of Major Rheumatoid Arthritis Drugs Manufacturers in 2015
Table China and Major Manufacturers of Rheumatoid Arthritis Drugs 2010-2015 (M USD)
Table Revenue Market Share of China Rheumatoid Arthritis Drugs Major Manufacturers 2010-2015
Table Global Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Rheumatoid Arthritis Drugs 2010-2015
Table China Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Rheumatoid Arthritis Drugs 2010-2015
Figure Bristol-Myers Squibb Co. Rheumatoid Arthritis Drugs Product Picture
Table Bristol-Myers Squibb Co. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Bristol-Myers Squibb Co. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Bristol-Myers Squibb Co. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Bristol-Myers Squibb Co. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Amgen Inc. Rheumatoid Arthritis Drugs Product Picture
Table Amgen Inc. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Amgen Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Amgen Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Amgen Inc. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure F. Hoffmann-La Roche Ltd. Rheumatoid Arthritis Drugs Product Picture
Table F. Hoffmann-La Roche Ltd. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 F. Hoffmann-La Roche Ltd. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 F. Hoffmann-La Roche Ltd. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 F. Hoffmann-La Roche Ltd. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Pfizer Inc. Rheumatoid Arthritis Drugs Product Picture
Table Pfizer Inc. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Pfizer Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Pfizer Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Pfizer Inc. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure AbbVie Inc. Rheumatoid Arthritis Drugs Product Picture
Table AbbVie Inc. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 AbbVie Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 AbbVie Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 AbbVie Inc. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Janssen Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Picture
Table Janssen Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Janssen Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Janssen Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Janssen Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Rigel Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Picture
Table Rigel Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Rigel Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Rigel Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Rigel Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Sanofi Rheumatoid Arthritis Drugs Product Picture
Table Sanofi Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Sanofi Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Sanofi Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Sanofi Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Takeda Pharmaceutical Co. Ltd. Rheumatoid Arthritis Drugs Product Picture
Table Takeda Pharmaceutical Co. Ltd. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Takeda Pharmaceutical Co. Ltd. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Takeda Pharmaceutical Co. Ltd. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Takeda Pharmaceutical Co. Ltd. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure UCB SA Rheumatoid Arthritis Drugs Product Picture
Table UCB SA Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 UCB SA Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 UCB SA Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 UCB SA Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Vertex Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Picture
Table Vertex Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Vertex Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Vertex Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Vertex Pharmaceuticals Inc. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Incyte Corp. Rheumatoid Arthritis Drugs Product Picture
Table Incyte Corp. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Incyte Corp. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Incyte Corp. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Incyte Corp. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Merck and Co. Inc. Rheumatoid Arthritis Drugs Product Picture
Table Merck and Co. Inc. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Merck and Co. Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Merck and Co. Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Merck and Co. Inc. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Mitsubishi Tanabe Pharma Corp. Rheumatoid Arthritis Drugs Product Picture
Table Mitsubishi Tanabe Pharma Corp. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Mitsubishi Tanabe Pharma Corp. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Mitsubishi Tanabe Pharma Corp. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Mitsubishi Tanabe Pharma Corp. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Novartis AG Rheumatoid Arthritis Drugs Product Picture
Table Novartis AG Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Novartis AG Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Novartis AG Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Novartis AG Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Novo Nordisk A/S Rheumatoid Arthritis Drugs Product Picture
Table Novo Nordisk A/S Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Novo Nordisk A/S Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Novo Nordisk A/S Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Novo Nordisk A/S Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Daiichi Sankyo Co. Ltd. Rheumatoid Arthritis Drugs Product Picture
Table Daiichi Sankyo Co. Ltd. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Daiichi Sankyo Co. Ltd. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Daiichi Sankyo Co. Ltd. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Daiichi Sankyo Co. Ltd. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Eli Lilly and Co. Rheumatoid Arthritis Drugs Product Picture
Table Eli Lilly and Co. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Eli Lilly and Co. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Eli Lilly and Co. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Eli Lilly and Co. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure GE Healthcare Co. Rheumatoid Arthritis Drugs Product Picture
Table GE Healthcare Co. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 GE Healthcare Co. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 GE Healthcare Co. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 GE Healthcare Co. Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Genmab A/S Rheumatoid Arthritis Drugs Product Picture
Table Genmab A/S Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Genmab A/S Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Genmab A/S Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 Genmab A/S Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure GSK plc Rheumatoid Arthritis Drugs Product Picture
Table GSK plc Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 GSK plc Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 GSK plc Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 GSK plc Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure AstraZeneca plc Rheumatoid Arthritis Drugs Product Picture
Table AstraZeneca plc Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 AstraZeneca plc Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 AstraZeneca plc Rheumatoid Arthritis Drugs Product Capacity Production (K MT) and Growth Rate
Figure 2010-2015 AstraZeneca plc Rheumatoid Arthritis Drugs Product Production Global Market Share
Figure Biogen Idec Inc. Rheumatoid Arthritis Drugs Product Picture
Table Biogen Idec Inc. Rheumatoid Arthritis Drugs Product Specification
Table 2010-2015 Biogen Idec Inc. Rheumatoid Arthritis Drugs Product Capacity Production (K MT) Price Cost Gross (USD/MT) Production Value (M USD) Gross Margin List
Figure 2010-2015 Biogen Idec Inc. Rheumatoid Arthritis Drugs Product Capa

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Rheumatoid Arthritis in 17 Major Markets Rheumatoid arthritis (RA) is classified as an autoimmune disease and occurs when the immune ...

Epiomic Epidemiology Series: Osteoarthritis Forecast in 9 Major Markets 2016-2026

Epiomic Epidemiology Series: Osteoarthritis Forecast in 9 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Osteoarthritis in 9 Major Markets Osteoarthritis (OA), also known as degenerative joint disease / degenerative arthritis, is an inflammation ...

Osteoarthritis  - Market Insights, Epidemiology and Market Forecast-2023

Osteoarthritis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Osteoarthritis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.